{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:50:05Z","timestamp":1775487005176,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014934","name":"Avanir Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014934","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["KO-2 MH00095"],"award-info":[{"award-number":["KO-2 MH00095"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["RO-1 MH46848"],"award-info":[{"award-number":["RO-1 MH46848"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001455","name":"American Foundation for Suicide Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001455","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.biopsych.2012.02.023","type":"journal-article","created":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T14:01:21Z","timestamp":1332597681000},"page":"238-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cerebrospinal Fluid Substance P-Like Immunoreactivity Correlates with Aggression in Personality Disordered Subjects"],"prefix":"10.1016","volume":"72","author":[{"given":"Emil F.","family":"Coccaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Royce","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Becky","family":"Kinkead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles B.","family":"Nemeroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2012.02.023_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1357-2725(01)00031-0","article-title":"Substance P","volume":"33","author":"Harrison","year":"2001","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1568026043451636","article-title":"Substance P: Structure, function, and therapeutics","volume":"4","author":"Atar","year":"2004","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.biopsych.2012.02.023_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1113\/jphysiol.1931.sp002763","article-title":"An unidentified depressor substance in certain tissue extracts","volume":"72","author":"von Euler","year":"1931","journal-title":"J Physiol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0306-3623(94)00292-U","article-title":"The mammalian tachykinin receptors","volume":"26","author":"Maggi","year":"1995","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-0115(00)00228-7","article-title":"Localization of NK1 and NK3 receptors in guinea-pig brain","volume":"98","author":"Yip","year":"2001","journal-title":"Regul Pept"},{"key":"10.1016\/j.biopsych.2012.02.023_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.euroneuro.2006.07.004","article-title":"Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function","volume":"17","author":"Gobbi","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib7","first-page":"195","article-title":"Substance P: Transmitter of nociception (minireview)","volume":"34","author":"Zubrzycka","year":"2000","journal-title":"Endocr Regul"},{"key":"10.1016\/j.biopsych.2012.02.023_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00726-006-0335-9","article-title":"The role of substance P in stress and anxiety responses","volume":"31","author":"Ebner","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.biopsych.2012.02.023_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF02244906","article-title":"Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity","volume":"112","author":"Huston","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2012.02.023_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3171\/JNS-07\/09\/0593","article-title":"Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions","volume":"107","author":"Park","year":"2007","journal-title":"J Neurosurg"},{"key":"10.1016\/j.biopsych.2012.02.023_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cne.903500103","article-title":"Distribution of messenger RNAs encoding enkephalin, substance P, somatostatin, galanin, vasoactive intestinal polypeptide, neuropeptide Y, and calcitonin gene-related peptide in the midbrain periaqueductal grey in the rat","volume":"350","author":"Smith","year":"1994","journal-title":"J Comp Neurology"},{"key":"10.1016\/j.biopsych.2012.02.023_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0006-8993(02)04189-6","article-title":"NK1 receptors in the medial hypothalamus potentiate defensive rage behavior elicited from the midbrain periaqueductal gray of the cat","volume":"966","author":"Bhatt","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2012.02.023_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0278-5846(00)00150-0","article-title":"Brain structures and neurotransmitters regulating aggression in cats: Implications for human aggression","volume":"25","author":"Gregg","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.02.023_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0006-8993(95)01586-8","article-title":"Medial amygdaloid suppression of predatory attack behavior in the cat: I","volume":"716","author":"Han","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2012.02.023_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-8993(93)91070-9","article-title":"Evidence that substace P is utilized in medial amygdaloid facilitation of defensive rage behavior in the cat","volume":"625","author":"Shaikh","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2012.02.023_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2003.09.024","article-title":"Differential effects of NK1 receptors in the midbrain periaqueductal gray upon defensive rage and predatory attack in the cat","volume":"994","author":"Gregg","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2012.02.023_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0091-3057(91)90149-V","article-title":"Vasoactive intestinal polypeptide (VIP) potentiates the behavioral effect of substance P intrathecal administration","volume":"39","author":"Beyer","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2012.02.023_bib18","first-page":"239","article-title":"Behavioral effects of substance P in rats","volume":"14","author":"Barbeau","year":"1980","journal-title":"Int J Neurol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0006-8993(86)90691-8","article-title":"Behavioural effects of tachykinins and related peptides","volume":"381","author":"Elliott","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2012.02.023_bib20","series-title":"Diagnostic and Statistical Manual: Fourth Edition (DSM-IV)","year":"1994"},{"key":"10.1016\/j.biopsych.2012.02.023_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.comppsych.2010.05.006","article-title":"Intermittent explosive disorder: Development of integrated research criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition","volume":"52","author":"Coccaro","year":"2011","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.biopsych.2012.02.023_bib22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jpsychires.2004.09.005","article-title":"High prevalence of personality disorders among healthy volunteers for research: Implications for control group bias","volume":"39","author":"Bunce","year":"2005","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2012.02.023_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-1781(97)00119-4","article-title":"Assessment of life history of aggression: Development and psychometric characteristics","volume":"73","author":"Coccaro","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.02.023_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/h0046900","article-title":"An inventory for assessing different kinds of hostility","volume":"21","author":"Buss","year":"1957","journal-title":"J Consult Psychol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.2044-8260.1977.tb01003.x","article-title":"The place of impulsiveness in a dimensional system of personality description","volume":"16","author":"Eysenck","year":"1977","journal-title":"Br J Soc Clin Psychol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the Barratt impulsiveness scale","volume":"51","author":"Patton","year":"1995","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/npp.2009.148","article-title":"Aggression, suicidality, and intermittent explosive disorder: Serotonergic correlates in personality disorder and healthy control subjects","volume":"35","author":"Coccaro","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.02.023_bib28","series-title":"Manual of the Eysenck Personality Questionnaire","author":"Eysenck","year":"1975"},{"key":"10.1016\/j.biopsych.2012.02.023_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00702-009-0359-x","article-title":"Cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid: Reciprocal relationships with impulsive aggression in human subjects","volume":"117","author":"Coccaro","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.biopsych.2012.02.023_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/305143a0","article-title":"A VIP-containing system concentrated in the lumbosacral region of human spinal cord","volume":"305","author":"Anand","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2012.02.023_bib31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/978-3-540-79090-7_11","article-title":"Sensory-nerve-derived neuropeptides: Possible therapeutic targets","volume":"194","author":"Fernandes","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib32","article-title":"Substance P in human CSF","volume":"Vol. 2","author":"Nutt","year":"1983"},{"key":"10.1016\/j.biopsych.2012.02.023_bib33","first-page":"108","article-title":"Some observations indicating a low brain uptake of [3H]Nle11-Substance P","volume":"38","author":"Landgraf","year":"1983","journal-title":"Pharmazie"},{"key":"10.1016\/j.biopsych.2012.02.023_bib34","first-page":"509","article-title":"Elevation of substance P-like peptides in the CSF of psychiatric patients","volume":"19","author":"Rim\u00f3n","year":"1984","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.02.023_bib35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1176\/ajp.2006.163.4.637","article-title":"Elevated cerebrospinal fluid substance P concentrations in posttraumatic stress disorder and major depression","volume":"163","author":"Geracioti","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.02.023_bib36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1440-1819.2009.01936.x","article-title":"Plasma and cerebrospinal fluid substance P in post-stroke patients with depression","volume":"63","author":"Li","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2012.02.023_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.psychres.2007.04.016","article-title":"Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy","volume":"157","author":"Carpenter","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.02.023_bib38","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00001756-200207020-00031","article-title":"Neurokinin-1 receptors are decreased in major depressive disorder","volume":"13","author":"Stockmeier","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2012.02.023_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0006-3223(99)00264-4","article-title":"Substance P (NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia","volume":"47","author":"Burnet","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.02.023_bib40","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0006-3223(02)01544-5","article-title":"Substance P serum levels are increased in major depression: preliminary results","volume":"53","author":"Bondy","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.02.023_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2004.12.007","article-title":"Substance P in serum and cerebrospinal fluid of depressed patients: No effect of antidepressant treatment","volume":"136","author":"Deuschle","year":"2005","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.02.023_bib42","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1126\/science.281.5383.1640","article-title":"Distinct mechanism for antidepressant activity by blockade of central substance P receptors","volume":"281","author":"Kramer","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2012.02.023_bib43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biopsych.2005.07.013","article-title":"Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder","volume":"59","author":"Keller","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.02.023_bib44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1526-4610.1997.3704211.x","article-title":"Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia","volume":"37","author":"Strittmatter","year":"1997","journal-title":"Headache"},{"key":"10.1016\/j.biopsych.2012.02.023_bib45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0165-5728(93)90197-7","article-title":"Relationship of interleukin-1 beta and beta 2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type","volume":"48","author":"Martinez","year":"1993","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib46","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/32904","article-title":"Altered nociception, analgesia and aggression in mice lacking the receptor for substance P","volume":"392","author":"De Felipe","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2012.02.023_bib47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/(SICI)1096-9861(19980907)398:4<473::AID-CNE2>3.0.CO;2-#","article-title":"Immunocytochemical localization of substance P receptor in rat periaqueductal gray matter: A light and electron microscopic study","volume":"398","author":"Barbaresi","year":"1998","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0361-9230(92)90027-U","article-title":"Distribution of substance P-like immunoreactivity in guinea pig central nervous system","volume":"29","author":"Gallagher","year":"1992","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.biopsych.2012.02.023_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1748-1716.1992.tb09428.x","article-title":"Short-term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri-aqueductal grey and limbic regions of rat brain","volume":"146","author":"Rosen","year":"1992","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.biopsych.2012.02.023_bib50","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1523\/JNEUROSCI.03-07-01437.1983","article-title":"The peptidergic organization of the cat periaqueductal gray: II","volume":"3","author":"Moss","year":"1983","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2012.02.023_bib51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0143-4179(94)90079-5","article-title":"Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions","volume":"26","author":"Brodin","year":"1994","journal-title":"Neuropeptides"},{"key":"10.1016\/j.biopsych.2012.02.023_bib52","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.171.3972.703","article-title":"Neural pathways associated with hypothalamically elicited attach behavior in cats","volume":"171","author":"Chi","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2012.02.023_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-8993(71)90594-4","article-title":"Neuroanatomic projections related to biting attack elicited from hypothalamus in cats","volume":"35","author":"Chi","year":"1971","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2012.02.023_bib54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0149-7634(98)00040-2","article-title":"Neuropharmacology of brain-stimulation-evoked aggression","volume":"23","author":"Siegel","year":"1999","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2012.02.023_bib55","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.biopsych.2004.02.007","article-title":"Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant","volume":"55","author":"Bergstr\u00f6m","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.02.023_bib56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/157015907780866929","article-title":"The neurobiological bases for development of pharmacological treatments of aggressive disorders","volume":"5","author":"Siegel","year":"2007","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib57","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1523\/JNEUROSCI.09-01-00258.1989","article-title":"Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues","volume":"9","author":"Mantyh","year":"1989","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2012.02.023_bib58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cne.903470208","article-title":"Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat","volume":"347","author":"Nakaya","year":"1994","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbr.2006.02.011","article-title":"Increased volume and neuronal number of the basolateral nuclear group of the amygdaloid body in aggressive dogs","volume":"170","author":"Jacobs","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2012.02.023_bib60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.brainres.2006.04.099","article-title":"Neurokinin-1 receptor in the basolateral nuclear group of the canine amygdala\u2014comparative study in normal and aggressive dogs","volume":"170","author":"Jacobs","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2012.02.023_bib61","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ajmg.b.30506","article-title":"Tachykinin receptor 1 variants associated with aggression in suicidal behavior","volume":"144B","author":"Giegling","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.biopsych.2012.02.023_bib62","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hup.876","article-title":"Effects of substance P on memory and mood in healthy male subjects","volume":"22","author":"Herpfer","year":"2007","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib63","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1017\/S1461145709990150","article-title":"NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers","volume":"12","author":"McCabe","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2012.02.023_bib64","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archpsyc.63.6.669","article-title":"The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication","volume":"63","author":"Kessler","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.02.023_bib65","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4088\/JCP.08m04150","article-title":"A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder","volume":"70","author":"Coccaro","year":"2009","journal-title":"J Clin Psychiatry"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312001503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312001503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T14:57:40Z","timestamp":1757775460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322312001503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0006322312001503"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.02.023","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal Fluid Substance P-Like Immunoreactivity Correlates with Aggression in Personality Disordered Subjects","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}